Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary vs Intravenous Abciximab in STEMI
NCT01757457Phase 4Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Maggiore della Carità
- Start
- Apr 2006
- Primary completion
- Apr 2008
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of abciximab in ST elevation myocardial infarction (STEMI), sponsored by Azienda Ospedaliero-Universitaria Maggiore della Carità. Started Apr 2006; status: completed.
02
Drugs
abciximab
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01757457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01757457.